Source comparison
Melanotan-1 40s Age Specific Protocol: Comparison Table
20–30 years 0.5mg daily 2–3 weeks 1.0mg daily 100% (baseline) Standard Low. Melanocytes respond uniformly Standard protocols work well; rapid titration is safe 30–40 years 0.25–0.5mg daily 3–4 weeks 0.75–1.0mg daily 85–90% Slightly reduced Moderate. Some UV da
This comparison does not assign a generated winner or score.
- 20–30 years
- 0.5mg daily
- 2–3 weeks
- 1.0mg daily
- 100% (baseline)
- Standard
- Low. Melanocytes respond uniformly
- Standard protocols work well; rapid titration is safe
- 30–40 years
- 0.25–0.5mg daily
- 3–4 weeks
- 0.75–1.0mg daily
- 85–90%
- Slightly reduced
- Moderate. Some UV damage present
- Begin dose moderation; watch for patchy response
- 40–50 years
- 0.25mg every other day
- 4–6 weeks
- 0.5–0.75mg daily
- 70–80%
- Reduced by ~10–15%
- High. Decades of photoaging create irregular melanocyte zones
- Slower titration essential; lower ceiling prevents overstimulation
- 50+ years
- 0.25mg every 3 days
- 6–8 weeks
- 0.5mg daily or every other day
- 60–70%
- Reduced by ~20–25%
- Very high. Significant melanocyte depletion in sun-exposed areas
- Conservative dosing only; UV exposure must be strictly controlled